Health
Singapore develops potential antibody treatment for yellow fever – BSA bureau
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
Researchers from Antimicrobial Resistance (AMR), an interdisciplinary group at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed TY014, a potential antibody treatment for yellow fever. SMART AMR collaborated with researchers from Massachusetts Institute of Technology (MIT), and local institutions such as the Singapore Ge…
-
Noosa News14 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General13 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General20 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
Noosa News22 hours agoInquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family